Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(24 sites)
United States
Mayo Clinic Arizona, Phoenix, Arizona University of California Los Angeles, Los Angeles, California Sarcoma Oncology Center, Santa Monica, California Stanford Medicine Cancer Institute, Stanford, California University of Colorado Denver, Aurora, Colorado Mayo Clinic Jacksonville, Jacksonville, Florida University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida Northwestern University, Chicago, Illinois University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan Mayo Clinic Rochester, Rochester, Minnesota Washington University St. Louis, St Louis, Missouri Columbia University Medical Center, New York, New York Thomas Jefferson Hospital - Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Vanderbilt University, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas UW Medicine-Seattle Cancer Care Alliance, Seattle, Washington China
Beijing Cancer Hospital, Beijing Shanghai Sixth People's Hospital, Shanghai Italy
Istituto Nazionale dei Tumori, Milan University of Palermo, Palermo University Campus Bio-Medico, Rome Spain
Hospital de la Santa Creu i Sant Pau, Barcelona United Kingdom
Royal Marsden Hospital, London